Infinitus’s proprietary patented Folium Cyclocarya Paliurus Extract has been approved to be included in the Therapeutic Goods Administration of Australia (TGA) list. With this approval, Infinitus has been approved to commence research and development as well as the sale of complementary medicines within the Australia and New Zealand regions for this ingredient.
Being included on the TGA list signifies that an ingredient meets the organization’s strict regulatory requirements and passed comprehensive toxicological safety assessments. Less than 40% of applicants received TGA approval in 2021.
Folium Cyclocarya Paliurus Extract is a key component to the company’s S-Harmony Herbal Vege Capsules, which is part of the company’s approach to help consumers maintain healthy blood glucose levels.
“As we progress, Infinitus will remain committed to producing high-quality Chinese herbal products, while advocating the premium Chinese health regimen, co-creating healthier and happier lives for all,” the company wrote in a statement.